Literature DB >> 28267235

Red Blood Cells for Glucose-Responsive Insulin Delivery.

Chao Wang1,2, Yanqi Ye1,2, Wujin Sun1,2, Jicheng Yu1,2, Jingqiang Wang1,2, David S Lawrence3,4,5, John B Buse6, Zhen Gu1,2,6.   

Abstract

Glucose-responsive delivery of insulin mimicking the function of pancreatic β-cells to achieve meticulous control of blood glucose (BG) would revolutionize diabetes care. Here the authors report the development of a new glucose-responsive insulin delivery system based on the potential interaction between the glucose derivative-modified insulin (Glc-Insulin) and glucose transporters on erythrocytes (or red blood cells, RBCs) membrane. After being conjugated with the glucosamine, insulin can efficiently bind to RBC membranes. The binding is reversible in the setting of hyperglycemia, resulting in fast release of insulin and subsequent drop of BG level in vivo. The delivery vehicle can be further simplified utilizing injectable polymeric nanocarriers coated with RBC membrane and loaded with Glc-Insulin. The described work is the first demonstration of utilizing RBC membrane to achieve smart insulin delivery with fast responsiveness.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  diabetes; drug delivery; glucose response; insulin; red blood cell

Mesh:

Substances:

Year:  2017        PMID: 28267235     DOI: 10.1002/adma.201606617

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  22 in total

Review 1.  Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation.

Authors:  Jinqiang Wang; Zejun Wang; Jicheng Yu; Anna R Kahkoska; John B Buse; Zhen Gu
Journal:  Adv Mater       Date:  2019-08-18       Impact factor: 30.849

Review 2.  Development of glucose-responsive 'smart' insulin systems.

Authors:  Nischay K Rege; Nelson F B Phillips; Michael A Weiss
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-08       Impact factor: 3.243

3.  Bioinspired and Biomimetic Nanomedicines.

Authors:  Zhaowei Chen; Zejun Wang; Zhen Gu
Journal:  Acc Chem Res       Date:  2019-04-12       Impact factor: 22.384

4.  Visible-Light-Activated High-Density Materials for Controlled in Vivo Insulin Release.

Authors:  Bhagyesh R Sarode; Karen Kover; Simon H Friedman
Journal:  Mol Pharm       Date:  2019-10-24       Impact factor: 4.939

5.  Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.

Authors:  Jinqiang Wang; Zejun Wang; Guojun Chen; Yanfang Wang; Tianyuan Ci; Hongjun Li; Xiangsheng Liu; Daojia Zhou; Anna R Kahkoska; Zhuxian Zhou; Huan Meng; John B Buse; Zhen Gu
Journal:  ACS Nano       Date:  2021-03-08       Impact factor: 15.881

Review 6.  Glucose-Responsive Insulin Through Bioconjugation Approaches.

Authors:  Maria M Disotuar; Diao Chen; Nai-Pin Lin; Danny Hung-Chieh Chou
Journal:  J Diabetes Sci Technol       Date:  2019-06-19

7.  Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts.

Authors:  Mary Courtney Moore; David E Kelley; Raul C Camacho; Peter Zafian; Tian Ye; Songnian Lin; Niels C Kaarsholm; Ravi Nargund; Terri M Kelly; Margaret Van Heek; Stephen F Previs; Christopher Moyes; Marta S Smith; Ben Farmer; Phil Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2018-03-14       Impact factor: 9.461

Review 8.  Advances in bioresponsive closed-loop drug delivery systems.

Authors:  Jicheng Yu; Yuqi Zhang; Junjie Yan; Anna R Kahkoska; Zhen Gu
Journal:  Int J Pharm       Date:  2017-11-27       Impact factor: 5.875

Review 9.  Supramolecular metal-based nanoparticles for drug delivery and cancer therapy.

Authors:  Xiaomin Jiang; Chunbai He; Wenbin Lin
Journal:  Curr Opin Chem Biol       Date:  2021-02-22       Impact factor: 8.822

Review 10.  Developing Insulin Delivery Devices with Glucose Responsiveness.

Authors:  Zejun Wang; Jinqiang Wang; Anna R Kahkoska; John B Buse; Zhen Gu
Journal:  Trends Pharmacol Sci       Date:  2020-11-26       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.